Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
about
Biomarkers for nutrient intake with focus on alternative sampling techniquesGut Bacteria and Hydrogen Sulfide: The New Old Players in Circulatory System HomeostasisUrinary N-methylnicotinamide and β-aminoisobutyric acid predict catch-up growth in undernourished Brazilian children.Microbiota Is Involved in Post-resection Adaptation in Humans with Short Bowel Syndrome.Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke.Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC.Dietary pea fibre alters the microbial community and fermentation with increase in fibre degradation-associated bacterial groups in the colon of pigs.The prebiotic concept and human health: a changing landscape with riboflavin as a novel prebiotic candidate?Role of Neurochemicals in the Interaction between the Microbiota and the Immune and the Nervous System of the Host Organism.Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.The Nutritional and Safety Challenges Associated with Lupin Lacto-Fermentation.Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiotaImpact of Glycosidic Bond Configuration on Short Chain Fatty Acid Production from Model Fermentable Carbohydrates by the Human Gut Microbiota.ZBP-89 function in colonic stem cells and during butyrate-induced senescence.Mouse models for human intestinal microbiota research: a critical evaluation.Recent Development of Prebiotic Research-Statement from an Expert Workshop.Development of a fast and cost-effective gas chromatography-mass spectrometry method for the quantification of short-chain and medium-chain fatty acids in human biofluids.A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults.Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.Gastrointestinal Transit Time, Glucose Homeostasis and Metabolic Health: Modulation by Dietary Fibers.The role of the microbiome for human health: from basic science to clinical applications.Effects of Dietary Arginine, Ornithine, and Zeolite Supplementation on Uremic Toxins in Cats.Managing portal hypertension in patients with liver cirrhosis.Effect of a Protein Supplement on the Gut Microbiota of Endurance Athletes: A Randomized, Controlled, Double-Blind Pilot Study.Effects of Psychological, Environmental and Physical Stressors on the Gut MicrobiotaImmunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and PhagesButyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of to Healthy Volunteers
P2860
Q26739783-7270CDAF-A381-4BEF-87EE-18B2FEC41088Q28066350-7F5B98E0-6F67-4C0F-A8D6-50168B475246Q30277666-149D81F2-0BEB-4CD0-BBA2-58F1DBDF967CQ33575682-97654C6C-01A6-4E2B-9D1D-656783D1CB9BQ33918713-8B7D990E-6C40-47FB-A115-6E96F3253439Q36271749-648D3FE1-E5FD-41B6-A051-4BEC2D741A7FQ37486151-20206798-6C69-4771-ABA0-21EDDFFC0BF8Q38772843-637DBEF1-F533-4875-9FDF-50F9959210F1Q38813216-8DA2E46E-7474-4738-9EE6-4007C9DBE33FQ38886978-E5AC064B-DC84-4021-931A-D1BEB6BA85EDQ39147442-348EC60C-3E14-4A62-A5AD-E57BF97C6335Q39393210-5376B1F3-CE10-420C-8C68-EEE73B31D352Q42142137-4FFF1FA3-E374-4B7F-AD83-4FA984B775D5Q42144844-53B91CD5-ED10-4CCF-ACC6-C521092BD10CQ42323462-E341D8AD-5E94-4305-85E2-EDFA6E17A340Q47098252-63814339-44D1-4250-941F-928E8E92E7D6Q47620267-2D680DD2-2196-45C3-95DC-30D58D460B87Q47772002-2D601F35-B0DA-4A7C-B0B5-00938319B75EQ47968131-DF4B5D41-766F-4F5E-A996-CE3049E97917Q48509358-A51847E7-D2C2-4ABB-A104-0452D773A287Q49650701-71D5C72F-9658-4AB8-8949-E89DBE4A9C57Q50193587-30B53DB1-3326-423C-8197-091F043305DBQ52679038-4F115A92-FA57-459D-A52D-1B10F939116DQ54214888-E1D40837-BCD2-4FF0-A357-98CBCDA3E29EQ55112894-1AF4EC07-E0CB-4061-9D6B-E3A86199E35EQ55278061-14DD7EF5-0AEB-42F3-9747-F621CF6F8F56Q55413458-8DDBF6B6-E07E-41B5-BDB7-AF82112F33D0Q57091526-D4E2A370-CDB1-43AA-B5B8-5CC3A0A4C64DQ57816699-3D1EA340-ACB6-465D-827F-BCF6C3420552Q58699938-67E25DC2-5F30-4114-AE3A-5ECF09B7489B
P2860
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
@ast
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
@en
type
label
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
@ast
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
@en
prefLabel
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
@ast
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
@en
P2093
P2860
P50
P921
P1476
Towards microbial fermentation metabolites as markers for health benefits of prebiotics.
@en
P2093
Alan R Boobis
Anne Franck
Arjen Nauta
Eric A F van Tol
Kristin A Verbeke
P2860
P356
10.1017/S0954422415000037
P577
2015-06-01T00:00:00Z